Dr. Ivana Barbaric discusses how genetic mutations in hPSCs cultured in vitro confer selective advantages that can affect cell behavior and confound experimental results through the elimination of wild-type cells. Dr. Barbaric is a group leader at the Center for Stem Cell Biology, University of Sheffield, UK.
To view the webinar, please complete the form, or sign in to your account.
StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.